RA Capital Team
Photo of Anthony Arceci, Associate at RA Capital
Anthony Arceci
RA Capital·Associate
Sweet spot: $1.5M
Range: $100K - $1.5M
Investors in Boston (MA)
Investors in Diagnostics (Series B), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Medical Devices (Seed), Investors in Medical Devices (Series A), Investors in Digital Health (Series B), Investors in Diagnostics (Series B), Investors in Boston / New England (Other Lists), Investors in Pharmaceuticals (Seed), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in BioTech (Series B), Investors in Pharmaceuticals (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Diagnostics (Series A), Investors in Health & Hospital Services (Series A), Investors in Diagnostics (Seed), Investors in Health IT (Series A), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in BioTech (Series A), Investors in Medical Devices (Series B), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series B), Investors in Medical Devices (Series A), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in Digital Health (Series B), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in BioTech (Seed), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed)
Photo of Daniel Bahcheli, Associate at RA Capital
Daniel Bahcheli
RA Capital·Associate
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
Photo of Peter Balogh, Senior Associate at RA Capital
Peter Balogh
RA Capital·Senior Associate
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Medical Devices (Series A), Investors in Medical Devices (Seed), Investors in Digital Health (Series B), Investors in Diagnostics (Series B), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Series A), Investors in Health IT (Series B), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in BioTech (Series A), Investors in Medical Devices (Series B), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series B), Investors in Medical Devices (Series A), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in Digital Health (Series B), Investors in Boston / New England (Other Lists), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in BioTech (Seed), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed)
Photo of Gunes Bozkurt, Analyst at RA Capital
Gunes Bozkurt
RA Capital·Analyst
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Cambridge (MA)
Investors in Pharmaceuticals (Series B), Investors in BioTech (Series B), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series B), Investors in Boston / New England (Other Lists), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in BioTech (Series A), Investors in BioTech (Seed)
Photo of Ross Chikarmane, Associate at RA Capital
Ross Chikarmane
RA Capital·Associate
Sweet spot: $100K
Range: $100K - $100K
Investors in Boston (MA)
Photo of Habib Dable, Venture Partner at RA Capital
Habib Dable
RA Capital·Venture Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Cambridge (MA)
Investors in Diagnostics (Series B), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Medical Devices (Series A), Investors in Medical Devices (Seed), Investors in Diagnostics (Series B), Investors in Pharmaceuticals (Series A), Investors in Digital Health (Series B), Investors in Pharmaceuticals (Seed), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series A), Investors in Diagnostics (Series A), Investors in Digital Health (Series A), Investors in Diagnostics (Seed), Investors in Digital Health (Seed), Investors in Health IT (Series A), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in Medical Devices (Series B), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Seed), Investors in Medical Devices (Seed), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A), Investors in Boston / New England (Other Lists), Investors in Health IT (Series B), Investors in BioTech (Series B), Investors in Digital Health (Series B), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Series A), Investors in BioTech (Series A), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed)
Photo of Nathan Davis, Analyst at RA Capital
Nathan Davis
RA Capital·Analyst
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
Investors in FinTech (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in FinTech (Seed), Investors in Boston / New England (Other Lists), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in FinTech (Series A), Investors in FinTech (Seed)
Photo of Maxwell DeNies, Senior Associate at RA Capital
Maxwell DeNies
RA Capital·Senior Associate
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Medical Devices (Seed), Investors in Medical Devices (Series A), Investors in Digital Health (Series B), Investors in Diagnostics (Series B), Investors in Health IT (Series B), Investors in BioTech (Series B), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series B), Investors in Pharmaceuticals (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Diagnostics (Series A), Investors in Health & Hospital Services (Series A), Investors in Diagnostics (Seed), Investors in Health IT (Series A), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in BioTech (Series A), Investors in Medical Devices (Series B), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series B), Investors in Medical Devices (Series A), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in Boston / New England (Other Lists), Investors in Digital Health (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in BioTech (Seed), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed)
Photo of Derek DiRocco, Partner at RA Capital
Derek DiRocco
RA Capital·Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
Investors in Therapeutics (Series B), Investors in Therapeutics (Series A), Investors in Therapeutics (Seed), Investors in Pharmaceuticals (Series B), Investors in Therapeutics (Series B), Investors in Therapeutics (Series A), Investors in Pharmaceuticals (Seed), Investors in Therapeutics (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series B), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series B), Investors in BioTech (Seed), Investors in Pharmaceuticals (Seed), Investors in Boston / New England (Other Lists), Investors in BioTech (Series B), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed)
Photo of Ramin Farzaneh-Far, Venture Partner at RA Capital
Ramin Farzaneh-Far
RA Capital·Venture Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
Investors in Diagnostics (Series B), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Medical Devices (Series A), Investors in Medical Devices (Seed), Investors in Diagnostics (Series B), Investors in Pharmaceuticals (Series A), Investors in Digital Health (Series B), Investors in Pharmaceuticals (Seed), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series A), Investors in Diagnostics (Series A), Investors in Digital Health (Series A), Investors in Diagnostics (Seed), Investors in Digital Health (Seed), Investors in Health IT (Series A), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in Medical Devices (Series B), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Seed), Investors in Medical Devices (Seed), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series B), Investors in Health IT (Series B), Investors in Digital Health (Series B), Investors in Health & Hospital Services (Series B), Investors in Boston / New England (Other Lists), Investors in Digital Health (Series A), Investors in BioTech (Series A), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed)
Photo of Cristina Ghenoiu, Principal at RA Capital
Cristina Ghenoiu
RA Capital·Principal
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
Investors in Diagnostics (Seed), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Medical Devices (Series A), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Series A), Investors in Diagnostics (Series B), Investors in Digital Health (Series B), Investors in Pharmaceuticals (Seed), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series A), Investors in Diagnostics (Series A), Investors in Digital Health (Series A), Investors in Diagnostics (Seed), Investors in Digital Health (Seed), Investors in Health IT (Series A), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in Medical Devices (Series B), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series B), Investors in Boston / New England (Other Lists), Investors in Pharmaceuticals (Seed), Investors in Medical Devices (Seed), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A), Investors in Health IT (Series B), Investors in BioTech (Series B), Investors in Digital Health (Series B), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Series A), Investors in BioTech (Series A), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed)
Photo of Cosmas Giallourakis, Venture Partner at RA Capital
Cosmas Giallourakis
RA Capital·Venture Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Cambridge (MA)
Investors in Diagnostics (Series B), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Medical Devices (Series A), Investors in Medical Devices (Seed), Investors in Diagnostics (Series B), Investors in Digital Health (Series B), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Seed), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series A), Investors in Diagnostics (Series A), Investors in Digital Health (Series A), Investors in Diagnostics (Seed), Investors in Digital Health (Seed), Investors in Health IT (Series A), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in Medical Devices (Series B), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series B), Investors in Boston / New England (Other Lists), Investors in Pharmaceuticals (Seed), Investors in Medical Devices (Seed), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series B), Investors in Health IT (Series B), Investors in Digital Health (Series B), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Series A), Investors in BioTech (Series A), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed)
MG
Michael Gillespie
RA Capital·Senior Associate
Sweet spot: $1.5M
Range: $100K - $1.5M
Investors in Boston (MA)
Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Medical Devices (Series A), Investors in Medical Devices (Seed), Investors in Digital Health (Series B), Investors in Diagnostics (Series B), Investors in Pharmaceuticals (Seed), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Diagnostics (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Diagnostics (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Medical Devices (Series A), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in Boston / New England (Other Lists), Investors in Digital Health (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in BioTech (Seed), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed)
Photo of Reza Halse, Partner at RA Capital
Reza Halse
RA Capital·Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Cambridge (MA)
Investors in Therapeutics (Series B), Investors in Therapeutics (Series A), Investors in Therapeutics (Seed), Investors in Therapeutics (Series B), Investors in Therapeutics (Series A), Investors in BioTech (Series B), Investors in Therapeutics (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in BioTech (Series B), Investors in Boston / New England (Other Lists), Investors in BioTech (Series A), Investors in BioTech (Seed)
Photo of Jenna Hebert, Associate at RA Capital
Jenna Hebert
RA Capital·Associate
Sweet spot: $1.5M
Range: $100K - $1.5M
Investors in Boston (MA)
Investors in Diagnostics (Series B), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Medical Devices (Series A), Investors in Medical Devices (Seed), Investors in Digital Health (Series B), Investors in Diagnostics (Series B), Investors in Health IT (Series B), Investors in Pharmaceuticals (Seed), Investors in Health & Hospital Services (Series B), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Diagnostics (Series A), Investors in Health & Hospital Services (Series A), Investors in Diagnostics (Seed), Investors in Health IT (Series A), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in BioTech (Series A), Investors in Medical Devices (Series B), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series B), Investors in Medical Devices (Series A), Investors in Boston / New England (Other Lists), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in Digital Health (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in BioTech (Seed), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed)
Photo of Peyman Hosseinchi, Associate at RA Capital
Peyman Hosseinchi
RA Capital·Associate
Sweet spot: $100K
Range: $100K - $5.0M
Investors in Boston (MA)
Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Medical Devices (Series A), Investors in Medical Devices (Seed), Investors in Digital Health (Series B), Investors in Diagnostics (Series B), Investors in Pharmaceuticals (Seed), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in BioTech (Series B), Investors in Pharmaceuticals (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Diagnostics (Series A), Investors in Health & Hospital Services (Series A), Investors in Diagnostics (Seed), Investors in Health IT (Series A), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Medical Devices (Series A), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in Digital Health (Series B), Investors in Boston / New England (Other Lists), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in BioTech (Seed), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed)
Photo of Sonia Kartha, Associate at RA Capital
Sonia Kartha
RA Capital·Associate
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
Investors in Therapeutics (Series A), Investors in Therapeutics (Seed), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Seed), Investors in Therapeutics (Series A), Investors in Therapeutics (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Seed), Investors in Boston / New England (Other Lists), Investors in BioTech (Series A), Investors in BioTech (Seed)
Photo of Peter Kolchinsky, Managing Partner at RA Capital
Peter Kolchinsky
RA Capital·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
Photo of Anurag Kondapalli, Principal at RA Capital
Anurag Kondapalli
RA Capital·Principal
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in New York (NY)
Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in New York City (Other Lists)
AL
Alyssa Larson
RA Capital·Associate
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in Medical Devices (Series B), Investors in Boston / New England (Other Lists), Investors in Pharmaceuticals (Series B), Investors in Medical Devices (Seed), Investors in Medical Devices (Series A), Investors in Digital Health (Series B), Investors in Diagnostics (Series B), Investors in Health & Hospital Services (Series B), Investors in Pharmaceuticals (Series A), Investors in Health IT (Series B), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in Digital Health (Series A), Investors in Diagnostics (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Diagnostics (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in Medical Devices (Series B), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series B), Investors in Medical Devices (Series A), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in Digital Health (Series B), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed)
Photo of Jon Lundt, Senior Associate at RA Capital
Jon Lundt
RA Capital·Senior Associate
Sweet spot: $1.5M
Range: $100K - $1.5M
Investors in Boston (MA)
Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Medical Devices (Series A), Investors in Medical Devices (Seed), Investors in Digital Health (Series B), Investors in Diagnostics (Series B), Investors in Pharmaceuticals (Seed), Investors in Health IT (Series B), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series B), Investors in BioTech (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in BioTech (Series A), Investors in Medical Devices (Series B), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series B), Investors in Medical Devices (Series A), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Series A), Investors in Boston / New England (Other Lists), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in Digital Health (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in BioTech (Seed), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed)
Photo of Dan Marks, Principal at RA Capital
Dan Marks
RA Capital·Principal
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
Investors in Diagnostics (Series B), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Medical Devices (Series A), Investors in Medical Devices (Seed), Investors in Diagnostics (Series B), Investors in Digital Health (Series B), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Seed), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in BioTech (Series B), Investors in Diagnostics (Series A), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Series A), Investors in Diagnostics (Seed), Investors in Digital Health (Seed), Investors in Health IT (Series A), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in Medical Devices (Series B), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series A), Investors in Boston / New England (Other Lists), Investors in Pharmaceuticals (Seed), Investors in Medical Devices (Series A), Investors in Medical Devices (Seed), Investors in BioTech (Series B), Investors in Health IT (Series B), Investors in Digital Health (Series B), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Series A), Investors in BioTech (Series A), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed)
Photo of David Migl, Senior Associate at RA Capital
David Migl
RA Capital·Senior Associate
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
Investors in Diagnostics (Series B), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Medical Devices (Series A), Investors in Medical Devices (Seed), Investors in Diagnostics (Series B), Investors in Digital Health (Series B), Investors in Pharmaceuticals (Seed), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in BioTech (Series B), Investors in Pharmaceuticals (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Diagnostics (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Diagnostics (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in BioTech (Series A), Investors in Medical Devices (Series B), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series B), Investors in Boston / New England (Other Lists), Investors in Medical Devices (Series A), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in Digital Health (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in BioTech (Seed), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed)
Photo of Emily Minkow, Venture Partner at RA Capital
Emily Minkow
RA Capital·Venture Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in New York (NY)
Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in Pharmaceuticals (Series B), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Series A), Investors in Diagnostics (Series B), Investors in BioTech (Series B), Investors in Digital Health (Series B), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Seed), Investors in Medical Devices (Series B), Investors in Health & Hospital Services (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series A), Investors in Health IT (Series A), Investors in Health IT (Seed), Investors in Pharmaceuticals (Seed), Investors in Medical Devices (Series A), Investors in Medical Devices (Seed), Investors in BioTech (Series B), Investors in Health IT (Series B), Investors in Digital Health (Series B), Investors in Health & Hospital Services (Series B), Investors in New York City (Other Lists), Investors in Digital Health (Series A), Investors in BioTech (Series A), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed)
Photo of Fuad Naser, Associate at RA Capital
Fuad Naser
RA Capital·Associate
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Medical Devices (Series A), Investors in Medical Devices (Seed), Investors in Diagnostics (Series B), Investors in Digital Health (Series B), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Series A), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in BioTech (Series B), Investors in Diagnostics (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Diagnostics (Seed), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in BioTech (Series A), Investors in Medical Devices (Series B), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series B), Investors in Medical Devices (Series A), Investors in Boston / New England (Other Lists), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in Digital Health (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed)
Photo of Zach Scheiner, Principal at RA Capital
Zach Scheiner
RA Capital·Principal
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
Investors in Therapeutics (Series B), Investors in Therapeutics (Series A), Investors in Therapeutics (Seed), Investors in Medical Devices (Series B), Investors in Therapeutics (Series B), Investors in Medical Devices (Series A), Investors in Medical Devices (Seed), Investors in Therapeutics (Series A), Investors in BioTech (Series B), Investors in Therapeutics (Seed), Investors in Medical Devices (Series B), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Medical Devices (Seed), Investors in Medical Devices (Series A), Investors in BioTech (Series B), Investors in Boston / New England (Other Lists), Investors in BioTech (Series A), Investors in BioTech (Seed)
Photo of Rajeev Shah, Managing Director at RA Capital
Rajeev Shah
RA Capital·Managing Director
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
Photo of Rebecca Silberman, Associate at RA Capital
Rebecca Silberman
RA Capital·Associate
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Cambridge (MA)
Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Medical Devices (Series A), Investors in Medical Devices (Seed), Investors in Digital Health (Series B), Investors in Diagnostics (Series B), Investors in Pharmaceuticals (Series A), Investors in Health IT (Series B), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Diagnostics (Series A), Investors in Health & Hospital Services (Series A), Investors in Diagnostics (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Series A), Investors in Health IT (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Medical Devices (Series A), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in Digital Health (Series B), Investors in Diverse Investors (Other Lists), Investors in Boston / New England (Other Lists), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed)
Photo of Jake Simson, Partner at RA Capital
Jake Simson
RA Capital·Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
Investors in Therapeutics (Series B), Investors in Therapeutics (Series A), Investors in Therapeutics (Seed), Investors in Therapeutics (Series B), Investors in Pharmaceuticals (Series B), Investors in Therapeutics (Series A), Investors in Pharmaceuticals (Seed), Investors in Therapeutics (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series B), Investors in Pharmaceuticals (Series B), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in Boston / New England (Other Lists), Investors in BioTech (Series A), Investors in BioTech (Seed)
Photo of Monica Stanciu, Associate at RA Capital
Monica Stanciu
RA Capital·Associate
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in United States
Photo of Laura Stoppel, Principal at RA Capital
Laura Stoppel
RA Capital·Principal
Sweet spot: $100K
Range: $100K - $5.0M
Investors in Somerville (MA)
Investors in Therapeutics (Series B), Investors in Therapeutics (Series A), Investors in Therapeutics (Seed), Investors in Therapeutics (Series B), Investors in Therapeutics (Series A), Investors in BioTech (Series B), Investors in Therapeutics (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in BioTech (Series B), Investors in Boston / New England (Other Lists), Investors in BioTech (Series A), Investors in BioTech (Seed)
Photo of Katherine Terranova, Associate at RA Capital
Katherine Terranova
RA Capital·Associate
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Medical Devices (Series A), Investors in Medical Devices (Seed), Investors in Digital Health (Series B), Investors in Diagnostics (Series B), Investors in Health IT (Series B), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series B), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Diagnostics (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Diagnostics (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in Medical Devices (Series B), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series B), Investors in Medical Devices (Series A), Investors in Medical Devices (Seed), Investors in Boston / New England (Other Lists), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in Digital Health (Series B), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed)
CT
Christy Tzu-yun Kuo
RA Capital·Senior Associate
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
Photo of Jack Vailas, Senior Associate at RA Capital
Jack Vailas
RA Capital·Senior Associate
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
Photo of Shan Shan Wang, Associate at RA Capital
Shan Shan Wang
RA Capital·Associate
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
Investors in BioTech (Series B), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in BioTech (Series B), Investors in Boston / New England (Other Lists), Investors in BioTech (Series A), Investors in BioTech (Seed)
Photo of Andrew Levin, Managing Partner at RA Capital
Andrew Levin
RA Capital·Managing Partner
Sweet spot: $0
Range: $0 - $0
Investors in Boston (MA)